US20060100584A1 - Needleless microprotrusion elastoplast system - Google Patents
Needleless microprotrusion elastoplast system Download PDFInfo
- Publication number
- US20060100584A1 US20060100584A1 US10/915,792 US91579204A US2006100584A1 US 20060100584 A1 US20060100584 A1 US 20060100584A1 US 91579204 A US91579204 A US 91579204A US 2006100584 A1 US2006100584 A1 US 2006100584A1
- Authority
- US
- United States
- Prior art keywords
- substrate
- microprotrusion
- microprotrusions
- patient
- chemodenervating agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/178—Syringes
- A61M5/30—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules
- A61M5/3007—Syringes for injection by jet action, without needle, e.g. for use with replaceable ampoules or carpules with specially designed jet passages at the injector's distal end
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/0023—Drug applicators using microneedles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0015—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles
- A61M2037/003—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin by using microneedles having a lumen
Definitions
- the present invention is generally directed to a delivery system for a medicament and is more particularly directed to a needleless microprotrusion system for infusion of a medicament into a patient.
- the present invention relates to a novel method of administering chemodenervating agents in a controlled and reproducible manner so as to confine effectiveness of the agent to a given region while minimizing the effects of the agent on adjacent tissue.
- Chemodenervating agents such as, for example, botulinum toxin, has been found effective for the treatment of hyperhidrosis and other dermological indications, such as glabellar lines and brow furrow.
- Current therapies include topicals, that is, for example, antiperspirants, creams and systemic products. All to often these are short acting and/or ineffective.
- each injection represents a possibility for infection
- the injections are typically spaced apart from one another, which results in peak and valley concentrations of the medicament.
- the epithelia layer of the skin also referred to as the epidermis, is a part of the skin which provides a barrier against penetration and consists of four layers. These layers are an outermost layer called the stratum corneum and three underlying layers called the stratum granulosum, the stratum malpighii, and the stratum germinativum.
- the present invention provides for a system for intradermal administration of neurotoxins in the treatment of hyperhidrosis, skin wrinkles including facial lines.
- the present invention provides for a needleless microprotrusion system for infusion of a medicament into a patient which includes a plurality of microprotrusions having a length sufficient to penetrate a stratum corneum of the patient and a chemodenervating agent disposed on or in the microprotrusions.
- a substrate is provided for supporting the microprotrusions with the substrate.
- the substrate features a shape for conforming to a selected patient body part in order to enable uniform penetration of the microprotrusions into the stratum corneum.
- two pluralities of microprotrusions are provided with one plurality of microprotrusions disposed on one side of the substrate and another plurality of microprotrusions disposed on another side of the substrate.
- a preferred shape for this embodiment includes a substrate sized for positioning within the palm of a patient and preferably the chemodenervating agent in accordance with the present invention comprises botulinum toxin, preferably type A.
- a method in accordance with the present invention utilizing this embodiment basically includes the steps providing a substrate having a shape for conforming to the palm of a patient with the substrate having microintrusions disposed on opposite sides of the substrates.
- the substrates have a length sufficient to penetrate the stratum corneum of the patients' palm.
- a chemodenervating agent is provided for delivery by the microprotrusions and the patent is instructed to dispose the substrate on one palm and press the other palm against the substrate in order to effect simultaneous delivery of the chemodenervating agent into both palms.
- a substrate is size and shaped for conforming to a patients armpit and in yet another embodiment of the present invention the substrate is sized and shaped for application to a glabellar region of the patient.
- an adhesive disposed on the substrate may be provided for temporarily adhering the substrate to a patients' skin at a selected location and is suitable for receiving the size and shape of the substrate.
- the substrate is preferably flexible.
- FIG. 1 is a side view of one embodiment of the present invention generally showing two pluralities of microprotrusions disposed on opposite sides of a substrate;
- FIGS. 2 and 3 illustrate the use of the system shown in FIG. 1 which includes a substrate sized for positioning within the palm of a user;
- FIGS. 4-5 show other embodiments of the system in accordance with the present invention utilizing a single plurality of microprotrusions and a substrate for supporting the microprotrusions and having a shape for conforming to a selected body part along with an adhesive for temporarily adhering a substrate to a patients' skin;
- FIGS. 6 and 7 illustrate application of the embodiment shown in FIGS. 4 and 5 ;
- FIG. 8 shows an alternative embodiment of the present invention in which the substrate is sized and shaped for fitting the fossa axillaris (armpit) of a patient;
- FIG. 9 shows and alternative embodiment of the present invention in which the substrate is sized and shaped for positioning against a users' palm and fingers;
- FIG. 10 shows an alternative embodiment of the present invention in whish the substrate is sized and shaped for positioning against a users' sole and toes;
- FIG. 11 is an enlarge view of the microprotrusions shown in FIGS. 1 and 4 .
- FIG. 1 With reference to FIG. 1 , there is shown a needleless microprotrusion system 10 in accordance with the present invention for infusion of a medicament (not shown) into a patient, also not shown in FIG. 1 .
- the system 10 generally includes two pluralities 12 , 14 of microprotrusions 16 , 18 disposed on opposite sides 20 , 22 of a substrate 24 .
- the microprotrusions 16 , 18 may be of any suitable size and configuration and formed from a metal, preferably stainless steel, or other inert material that are directly embedded into the substrate 22 which is preferably an inert platform such as silicone, or polypropylene. With the proper selection of materials, the microprotrusions and substrate may be formed unitarily.
- a chemodenervating agent preferably botulinum toxin, is disposed on the microprotrusions 16 , 18 and covered with a removable liner 32 in a conventional manner, said liner being removable for exposing the microprotrusions 16 , 18 for use.
- the substrate 22 is sized and shaped for conforming to a patients' palm 36 which enables a method in accordance with the present invention as illustrated in FIG. 3 in which a patient, following instructions, disposes the system 10 in one palm 36 and press another palm 38 against the system 10 in order to effect simultaneous delivery of the chemodenervating agent into both palms 36 , 38 .
- This method for delivering the medicament is suitable for treatment of hyperhidrosis.
- the substrate is flexible for enabling uniform penetration of the microprotrusions 16 , 18 into the patients' palms 36 , 38 respectively.
- Microprotrusions suitable for use in the present invention are described in U.S. Pat. No. 6,322,808 which is to be incorporated herewith in its entirety for a description of suitable microprotrusions 16 , 18 and substrates 24 .
- FIGS. 4 and 5 there are shown alternative embodiments 44 , 46 in accordance with the present invention which further include exposed portions 48 , 50 respectively which include an adhesive for temporarily adhering the substrate portions 48 , 50 to a patient, see FIGS. 6 and 7 respectively which illustrate application of the embodiment 44 for removing wrinkles adjacent a patients' eye and in a glabellar region of the patient.
- FIG. 8 In another embodiment 56 of the present invention as illustrated in FIG. 8 in which a substrate 58 is sized and shaped for fitting and conforming to a patients armpit 60 .
- FIGS. 9-10 are alternative embodiments 64 , 66 illustrating substrates 68 , 70 respectively, which are sized and shaped for positioning against a palm 74 and fingers 76 of a user and for positioning against a sole 80 and toes 80 of a user.
- Various glove sizes and shoe sizes may be used to produce embodiments 64 , 66 for use.
- FIG. 11 is an enlarged view of the microprotrusions 16 , which as hereinabove noted, may be coated with botulinum toxin or alternatively, filled with a solution including botulinum toxin.
- a reservoir 90 may be provided behind the microprotrusions 16 and covered by a backing 92 for enabling pressure to be exerted on the reservoir for effecting delivery of the botulinum toxin from the microprotrusion.
- microprotrusions are varied depending upon the anatomy of the particular tissue being targeted by the therapeutic neurotoxin.
Abstract
A needleless microprotrusion system for infusion of a medicament into a patient includes a plurality of microprotrusions having a length sufficient to penetrate a stratum corneum of the patient. A chemodenervating agent is disposed in a microprotrusions in a substrate is provided for supporting the microprotrusion and conforming the microprotrusions to a selected patient body part in order to enable uniform penetration of the microprotrusions into the corneum.
Description
- The present invention is generally directed to a delivery system for a medicament and is more particularly directed to a needleless microprotrusion system for infusion of a medicament into a patient.
- Still more particularly, the present invention relates to a novel method of administering chemodenervating agents in a controlled and reproducible manner so as to confine effectiveness of the agent to a given region while minimizing the effects of the agent on adjacent tissue.
- Chemodenervating agents such as, for example, botulinum toxin, has been found effective for the treatment of hyperhidrosis and other dermological indications, such as glabellar lines and brow furrow. Current therapies include topicals, that is, for example, antiperspirants, creams and systemic products. All to often these are short acting and/or ineffective.
- As noted, a significant advantage in ameliorating sweating and removing wrinkle lines has been achieved through the action of botulinum toxin injections. While this specific treatment is revolutionary and efficacious, the patient is unfortunately placed under significant amount of duress and discomfort due to need to administer multiple injections.
- In addition, since each injection represents a possibility for infection, the injections are typically spaced apart from one another, which results in peak and valley concentrations of the medicament.
- The epithelia layer of the skin, also referred to as the epidermis, is a part of the skin which provides a barrier against penetration and consists of four layers. These layers are an outermost layer called the stratum corneum and three underlying layers called the stratum granulosum, the stratum malpighii, and the stratum germinativum.
- The present invention provides for a system for intradermal administration of neurotoxins in the treatment of hyperhidrosis, skin wrinkles including facial lines.
- The present invention provides for a needleless microprotrusion system for infusion of a medicament into a patient which includes a plurality of microprotrusions having a length sufficient to penetrate a stratum corneum of the patient and a chemodenervating agent disposed on or in the microprotrusions.
- A substrate is provided for supporting the microprotrusions with the substrate. The substrate features a shape for conforming to a selected patient body part in order to enable uniform penetration of the microprotrusions into the stratum corneum.
- In one embodiment of the present invention, two pluralities of microprotrusions are provided with one plurality of microprotrusions disposed on one side of the substrate and another plurality of microprotrusions disposed on another side of the substrate.
- A preferred shape for this embodiment includes a substrate sized for positioning within the palm of a patient and preferably the chemodenervating agent in accordance with the present invention comprises botulinum toxin, preferably type A.
- A method in accordance with the present invention utilizing this embodiment basically includes the steps providing a substrate having a shape for conforming to the palm of a patient with the substrate having microintrusions disposed on opposite sides of the substrates. The substrates have a length sufficient to penetrate the stratum corneum of the patients' palm.
- A chemodenervating agent is provided for delivery by the microprotrusions and the patent is instructed to dispose the substrate on one palm and press the other palm against the substrate in order to effect simultaneous delivery of the chemodenervating agent into both palms.
- In another embodiment of the present invention a substrate is size and shaped for conforming to a patients armpit and in yet another embodiment of the present invention the substrate is sized and shaped for application to a glabellar region of the patient.
- In addition, an adhesive disposed on the substrate may be provided for temporarily adhering the substrate to a patients' skin at a selected location and is suitable for receiving the size and shape of the substrate.
- To further enhance uniform penetration of the microprotrusions into the stratum corneum, the substrate is preferably flexible.
- The present invention may be more clearly understood with reference to the following detailed description in conjunction with the appended drawings, of which:
-
FIG. 1 is a side view of one embodiment of the present invention generally showing two pluralities of microprotrusions disposed on opposite sides of a substrate; -
FIGS. 2 and 3 illustrate the use of the system shown inFIG. 1 which includes a substrate sized for positioning within the palm of a user; -
FIGS. 4-5 show other embodiments of the system in accordance with the present invention utilizing a single plurality of microprotrusions and a substrate for supporting the microprotrusions and having a shape for conforming to a selected body part along with an adhesive for temporarily adhering a substrate to a patients' skin; -
FIGS. 6 and 7 illustrate application of the embodiment shown inFIGS. 4 and 5 ; -
FIG. 8 shows an alternative embodiment of the present invention in which the substrate is sized and shaped for fitting the fossa axillaris (armpit) of a patient; -
FIG. 9 shows and alternative embodiment of the present invention in which the substrate is sized and shaped for positioning against a users' palm and fingers; -
FIG. 10 shows an alternative embodiment of the present invention in whish the substrate is sized and shaped for positioning against a users' sole and toes; and -
FIG. 11 is an enlarge view of the microprotrusions shown inFIGS. 1 and 4 . - With reference to
FIG. 1 , there is shown aneedleless microprotrusion system 10 in accordance with the present invention for infusion of a medicament (not shown) into a patient, also not shown inFIG. 1 . - The
system 10 generally includes twopluralities 12, 14 of microprotrusions 16, 18 disposed onopposite sides 20, 22 of asubstrate 24. - The microprotrusions 16, 18 may be of any suitable size and configuration and formed from a metal, preferably stainless steel, or other inert material that are directly embedded into the substrate 22 which is preferably an inert platform such as silicone, or polypropylene. With the proper selection of materials, the microprotrusions and substrate may be formed unitarily.
- A chemodenervating agent, preferably botulinum toxin, is disposed on the microprotrusions 16, 18 and covered with a removable liner 32 in a conventional manner, said liner being removable for exposing the microprotrusions 16, 18 for use.
- As more clearly shown in
FIGS. 2 and 3 , the substrate 22 is sized and shaped for conforming to a patients'palm 36 which enables a method in accordance with the present invention as illustrated inFIG. 3 in which a patient, following instructions, disposes thesystem 10 in onepalm 36 and press anotherpalm 38 against thesystem 10 in order to effect simultaneous delivery of the chemodenervating agent into bothpalms - This method for delivering the medicament is suitable for treatment of hyperhidrosis. Preferably, the substrate is flexible for enabling uniform penetration of the microprotrusions 16, 18 into the patients'
palms substrates 24. - With reference to
FIGS. 4 and 5 , there are shownalternative embodiments portions substrate portions FIGS. 6 and 7 respectively which illustrate application of theembodiment 44 for removing wrinkles adjacent a patients' eye and in a glabellar region of the patient. - In another embodiment 56 of the present invention as illustrated in
FIG. 8 in which asubstrate 58 is sized and shaped for fitting and conforming to a patients armpit 60. -
FIGS. 9-10 arealternative embodiments 64, 66illustrating substrates 68, 70 respectively, which are sized and shaped for positioning against apalm 74 andfingers 76 of a user and for positioning against a sole 80 andtoes 80 of a user. Various glove sizes and shoe sizes may be used to produceembodiments 64, 66 for use. -
FIG. 11 is an enlarged view of the microprotrusions 16, which as hereinabove noted, may be coated with botulinum toxin or alternatively, filled with a solution including botulinum toxin. - In this instance, a reservoir 90 may be provided behind the microprotrusions 16 and covered by a backing 92 for enabling pressure to be exerted on the reservoir for effecting delivery of the botulinum toxin from the microprotrusion.
- It should be appreciated that the length of the microprotrusions are varied depending upon the anatomy of the particular tissue being targeted by the therapeutic neurotoxin.
- Although there has been hereinabove described a specific needleless microprotrusion blastoplast system in accordance with the present invention for the purpose of illustrating the manner in which the invention may be used to advantage, it should be appreciated that the invention is not limited thereto. That is, the present invention may suitably comprise, consist of, or consist essentially of the recited elements. Further, the invention illustratively disclosed herein suitably may be practiced in the absence of any element which is not specifically disclosed herein. Accordingly, any and all modifications, variations or equivalent arrangements which may occur to those skilled in the art, should be considered to be within the scope of the present invention as defined in the appended claims.
Claims (21)
1. A needleless microprotrusion system for infusion of a medicament into a patient, the system comprising:
a plurality of microprotrusions having a length sufficient to penetrate a stratum corneum of the patient;
a chemodenervating agent disposed on surfaces of the microprotrusions;
a substrate for supporting the microprotrusions, said substrate having a shape for conforming to a selected patient body part in order to enable uniform penetration of the microprotrusions into said stratum corneum.
2. The system according to claim 1 further comprising two pluralities of microprotrusions, one plurality of microprotrusion dispose on one side of said substrate and another plurality of microprotrusion disposed on another side of said substrate.
3. The system according to claim 2 wherein said substrate is sized for positioning within a palm of said patient.
4. The system according to claim 1 wherein said substrate is sized and shaped for positioning against a palm and fingers of a user.
5. The system according to claim 1 wherein said substrate is sized and shaped for conforming to a patients' armpit.
6. The system according to claim 1 wherein said substrate is sized and shaped for positioning against a sole of a users' foot.
7. The system according to claim 1 wherein said substrate is sized and shaped for positioning against a sole and toes of a users' foot.
8. The system according to claim 1 wherein said substrate is sized and shaped for application to a glabellar region of said patient.
9. The system according to claim 1 further comprising an adhesive disposed on said substrate for temporary adhering said substrate to a patients' skin.
10. The system according to claim 7 further comprising an adhesive disposed on said substrate for temporary adhering said substrate to a patients' skin.
11. The system according to one of claims 9 and 10 wherein said adhesive surrounds said microprotrusion.
12. The system according to one of claims 1, 2, 3, 4, 5, 6, 7, 8, 9, and 10 wherein said substrate is flexible.
13. The system according to one of claims 1, 2, 3, 4, 5, 6, 7, 8, 9, and 10 wherein said chemodenervating agent is coated on said microprotrusion.
14. The system according to claim 13 wherein said chemodenervating agent comprises botulinum toxin.
15. The system according to one of claims 1, 2, 3, 4, 5, 6, 7, 8, 9, and 10 wherein said chemodenervating agent is disposed within said microprotrusion.
16. The system according to claim 15 wherein said chemodenervating agent comprises botulinum toxin.
17. A method for delivering a medicament to palms of a patient, said method comprising:
providing a substrate having a shape for conforming to a palm of a patient, said substrate having microprotrusion disposed on opposite sides of said substrate, said microprotrusion having a length sufficient to penetrate a stratum corneum of the patients' palm;
providing a chemodenervating agent for delivering by said microprotrusion; and
instructing said patient to dispose said substrate in one palm and press another palm against the substrate in order to effect simultaneous delivery of said chemodenervating agent into both palms.
18. The method according to claim 17 wherein said chemodenervating agent comprises botulinum toxin.
19. The method according to one of claims 17 and 18 further comprises providing a flexible substrate.
20. The method according to one of claims 17 and 18 further comprising coating the microprotrusion with said chemodenervating agent.
21. The method according to one of claims 17 and 18 further comprising filling the microprotrusions with said chemodenervating agent.
Priority Applications (15)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/915,792 US20060100584A1 (en) | 2004-08-10 | 2004-08-10 | Needleless microprotrusion elastoplast system |
JP2007525605A JP4824681B2 (en) | 2004-08-10 | 2005-06-02 | Needleless microprojection system |
AT05758761T ATE521384T1 (en) | 2004-08-10 | 2005-06-02 | NEEDLELESS MICROPROTRUSION ELASTOPLAST SYSTEM |
DK05758761.0T DK1786504T3 (en) | 2004-08-10 | 2005-06-02 | Needless micro-projection elastoplast system |
PCT/US2005/019489 WO2006022965A1 (en) | 2004-08-10 | 2005-06-02 | Needleless microprotrusion elastoplast system |
BRPI0514252-0A BRPI0514252A (en) | 2004-08-10 | 2005-06-02 | needleless microprotusion elastoplast system |
EP05758761A EP1786504B1 (en) | 2004-08-10 | 2005-06-02 | Needleless microprotrusion elastoplast system |
AU2005278015A AU2005278015A1 (en) | 2004-08-10 | 2005-06-02 | Needleless microprotrusion elastoplast system |
CA2576335A CA2576335C (en) | 2004-08-10 | 2005-06-02 | Needleless microprotrusion elastoplast system |
ES05758761T ES2370026T3 (en) | 2004-08-10 | 2005-06-02 | ELASTOPLAST NEEDLE MICROPROTRUSION SYSTEM. |
US11/600,576 US7390318B2 (en) | 2004-08-10 | 2006-11-16 | Needleless microprotrusion elastoplast system |
US11/601,258 US7479134B2 (en) | 2004-08-10 | 2006-11-16 | Method of delivering a medication |
US12/124,093 US20080221524A1 (en) | 2004-08-10 | 2008-05-20 | Needleless microprotrusion elastoplast system |
AU2012200981A AU2012200981B2 (en) | 2004-08-10 | 2012-02-20 | Needleless microprotrusion elastoplast system |
US13/758,729 US20130144252A1 (en) | 2004-08-10 | 2013-02-04 | Needless microprotrusion elastoplast system |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/915,792 US20060100584A1 (en) | 2004-08-10 | 2004-08-10 | Needleless microprotrusion elastoplast system |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/600,576 Division US7390318B2 (en) | 2004-08-10 | 2006-11-16 | Needleless microprotrusion elastoplast system |
US11/601,258 Division US7479134B2 (en) | 2004-08-10 | 2006-11-16 | Method of delivering a medication |
Publications (1)
Publication Number | Publication Date |
---|---|
US20060100584A1 true US20060100584A1 (en) | 2006-05-11 |
Family
ID=34981852
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/915,792 Abandoned US20060100584A1 (en) | 2004-08-10 | 2004-08-10 | Needleless microprotrusion elastoplast system |
US11/601,258 Active 2025-05-03 US7479134B2 (en) | 2004-08-10 | 2006-11-16 | Method of delivering a medication |
US11/600,576 Active US7390318B2 (en) | 2004-08-10 | 2006-11-16 | Needleless microprotrusion elastoplast system |
US12/124,093 Abandoned US20080221524A1 (en) | 2004-08-10 | 2008-05-20 | Needleless microprotrusion elastoplast system |
US13/758,729 Abandoned US20130144252A1 (en) | 2004-08-10 | 2013-02-04 | Needless microprotrusion elastoplast system |
Family Applications After (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/601,258 Active 2025-05-03 US7479134B2 (en) | 2004-08-10 | 2006-11-16 | Method of delivering a medication |
US11/600,576 Active US7390318B2 (en) | 2004-08-10 | 2006-11-16 | Needleless microprotrusion elastoplast system |
US12/124,093 Abandoned US20080221524A1 (en) | 2004-08-10 | 2008-05-20 | Needleless microprotrusion elastoplast system |
US13/758,729 Abandoned US20130144252A1 (en) | 2004-08-10 | 2013-02-04 | Needless microprotrusion elastoplast system |
Country Status (10)
Country | Link |
---|---|
US (5) | US20060100584A1 (en) |
EP (1) | EP1786504B1 (en) |
JP (1) | JP4824681B2 (en) |
AT (1) | ATE521384T1 (en) |
AU (2) | AU2005278015A1 (en) |
BR (1) | BRPI0514252A (en) |
CA (1) | CA2576335C (en) |
DK (1) | DK1786504T3 (en) |
ES (1) | ES2370026T3 (en) |
WO (1) | WO2006022965A1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080108958A1 (en) * | 2004-12-10 | 2008-05-08 | 3M Innovative Properties Company | Medical Device |
WO2017127840A1 (en) * | 2016-01-22 | 2017-07-27 | Transderm Inc. | Delivery of botulinum with microneedle arrays |
US10441767B2 (en) | 2010-10-27 | 2019-10-15 | Asti Corporation | Jig for microneedle array placement and microneedle array device |
US10603477B2 (en) | 2014-03-28 | 2020-03-31 | Allergan, Inc. | Dissolvable microneedles for skin treatment |
US11065428B2 (en) | 2017-02-17 | 2021-07-20 | Allergan, Inc. | Microneedle array with active ingredient |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120114697A1 (en) | 2002-08-19 | 2012-05-10 | Ira Sanders | Treatment of holocrine gland dysfunction with clostridia neurotoxins |
US7824693B2 (en) | 2002-08-19 | 2010-11-02 | Ira Sanders | Treatment of fine wrinkles with clostridia neurotoxins |
US20100286590A1 (en) * | 2009-05-08 | 2010-11-11 | Isis Biopolymer Llc | Iontophoretic device with improved counterelectrode |
US20110092881A1 (en) * | 2009-05-08 | 2011-04-21 | Isis Biopolymer Inc. | Iontophoretic device with contact sensor |
US8409147B2 (en) * | 2009-08-22 | 2013-04-02 | Joseph Wayne Kraft | Rapid local anesthesia linear injection device |
US8088108B2 (en) * | 2009-08-22 | 2012-01-03 | Joseph Wayne Kraft | Rapid local anesthesia injection cone |
US8147848B2 (en) | 2009-08-26 | 2012-04-03 | Allergan, Inc. | Method for treating premature ejaculation with a botulinum neurotoxin |
JP5797644B2 (en) * | 2010-05-28 | 2015-10-21 | 久光製薬株式会社 | Array with microprotrusions |
EP2578264B1 (en) * | 2010-05-28 | 2019-01-23 | Hisamitsu Pharmaceutical Co., Inc. | Device having array provided with fine protrusions |
KR20210040420A (en) * | 2018-08-15 | 2021-04-13 | 알레간 인코포레이티드 | Microneedle Array with Active Ingredients |
WO2020047159A1 (en) | 2018-08-28 | 2020-03-05 | Ira Sanders | Skin therapeutics |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5183462A (en) * | 1990-08-21 | 1993-02-02 | Associated Synapse Biologics | Controlled administration of chemodenervating pharmaceuticals |
US5611806A (en) * | 1994-05-23 | 1997-03-18 | Samsung Electro-Mechanics Co., Ltd. | Skin perforating device for transdermal medication |
US6322808B1 (en) * | 1997-12-11 | 2001-11-27 | Alza Corporation | Device for enhancing transdermal agent flux |
US6433003B1 (en) * | 1999-04-23 | 2002-08-13 | Arthur M. Bobrove | Method for treating hyperhidrosis in mammals |
US6485503B2 (en) * | 2000-05-19 | 2002-11-26 | Coapt Systems, Inc. | Multi-point tissue tension distribution device, a brow and face lift variation, and a method of tissue approximation using the device |
US6565532B1 (en) * | 2000-07-12 | 2003-05-20 | The Procter & Gamble Company | Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup |
US6659982B2 (en) * | 2000-05-08 | 2003-12-09 | Sterling Medivations, Inc. | Micro infusion drug delivery device |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3964482A (en) * | 1971-05-17 | 1976-06-22 | Alza Corporation | Drug delivery device |
US6256533B1 (en) * | 1999-06-09 | 2001-07-03 | The Procter & Gamble Company | Apparatus and method for using an intracutaneous microneedle array |
GB0017999D0 (en) * | 2000-07-21 | 2000-09-13 | Smithkline Beecham Biolog | Novel device |
US7108681B2 (en) * | 2000-10-16 | 2006-09-19 | Corium International, Inc. | Microstructures for delivering a composition cutaneously to skin |
AU2001297823B2 (en) * | 2000-10-26 | 2005-05-12 | Alza Corporation | Transdermal drug delivery devices having coated microprotrusions |
US6638246B1 (en) * | 2000-11-28 | 2003-10-28 | Scimed Life Systems, Inc. | Medical device for delivery of a biologically active material to a lumen |
US9302903B2 (en) * | 2000-12-14 | 2016-04-05 | Georgia Tech Research Corporation | Microneedle devices and production thereof |
AU2002312380A1 (en) * | 2001-06-08 | 2002-12-23 | Becton, Dickinson And Company | Device for manipulating a needle or abrader array |
AU2003243750A1 (en) * | 2002-06-25 | 2004-01-06 | Sung-Yun Kwon | Rapidly dissolving micro-perforator for drug delivery and other applications |
-
2004
- 2004-08-10 US US10/915,792 patent/US20060100584A1/en not_active Abandoned
-
2005
- 2005-06-02 DK DK05758761.0T patent/DK1786504T3/en active
- 2005-06-02 AT AT05758761T patent/ATE521384T1/en not_active IP Right Cessation
- 2005-06-02 AU AU2005278015A patent/AU2005278015A1/en not_active Abandoned
- 2005-06-02 EP EP05758761A patent/EP1786504B1/en active Active
- 2005-06-02 JP JP2007525605A patent/JP4824681B2/en not_active Expired - Fee Related
- 2005-06-02 ES ES05758761T patent/ES2370026T3/en active Active
- 2005-06-02 BR BRPI0514252-0A patent/BRPI0514252A/en not_active IP Right Cessation
- 2005-06-02 CA CA2576335A patent/CA2576335C/en not_active Expired - Fee Related
- 2005-06-02 WO PCT/US2005/019489 patent/WO2006022965A1/en active Application Filing
-
2006
- 2006-11-16 US US11/601,258 patent/US7479134B2/en active Active
- 2006-11-16 US US11/600,576 patent/US7390318B2/en active Active
-
2008
- 2008-05-20 US US12/124,093 patent/US20080221524A1/en not_active Abandoned
-
2012
- 2012-02-20 AU AU2012200981A patent/AU2012200981B2/en not_active Expired - Fee Related
-
2013
- 2013-02-04 US US13/758,729 patent/US20130144252A1/en not_active Abandoned
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5183462A (en) * | 1990-08-21 | 1993-02-02 | Associated Synapse Biologics | Controlled administration of chemodenervating pharmaceuticals |
US5611806A (en) * | 1994-05-23 | 1997-03-18 | Samsung Electro-Mechanics Co., Ltd. | Skin perforating device for transdermal medication |
US6322808B1 (en) * | 1997-12-11 | 2001-11-27 | Alza Corporation | Device for enhancing transdermal agent flux |
US6433003B1 (en) * | 1999-04-23 | 2002-08-13 | Arthur M. Bobrove | Method for treating hyperhidrosis in mammals |
US6659982B2 (en) * | 2000-05-08 | 2003-12-09 | Sterling Medivations, Inc. | Micro infusion drug delivery device |
US6485503B2 (en) * | 2000-05-19 | 2002-11-26 | Coapt Systems, Inc. | Multi-point tissue tension distribution device, a brow and face lift variation, and a method of tissue approximation using the device |
US6565532B1 (en) * | 2000-07-12 | 2003-05-20 | The Procter & Gamble Company | Microneedle apparatus used for marking skin and for dispensing semi-permanent subcutaneous makeup |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080108958A1 (en) * | 2004-12-10 | 2008-05-08 | 3M Innovative Properties Company | Medical Device |
US10441767B2 (en) | 2010-10-27 | 2019-10-15 | Asti Corporation | Jig for microneedle array placement and microneedle array device |
US10603477B2 (en) | 2014-03-28 | 2020-03-31 | Allergan, Inc. | Dissolvable microneedles for skin treatment |
US10987503B2 (en) | 2014-03-28 | 2021-04-27 | Allergan, Inc. | Dissolvable microneedles for skin treatment |
WO2017127840A1 (en) * | 2016-01-22 | 2017-07-27 | Transderm Inc. | Delivery of botulinum with microneedle arrays |
US11065428B2 (en) | 2017-02-17 | 2021-07-20 | Allergan, Inc. | Microneedle array with active ingredient |
Also Published As
Publication number | Publication date |
---|---|
US7390318B2 (en) | 2008-06-24 |
WO2006022965A1 (en) | 2006-03-02 |
US20130144252A1 (en) | 2013-06-06 |
CA2576335A1 (en) | 2006-03-02 |
EP1786504A1 (en) | 2007-05-23 |
US20070098773A1 (en) | 2007-05-03 |
ES2370026T3 (en) | 2011-12-12 |
BRPI0514252A (en) | 2008-06-03 |
EP1786504B1 (en) | 2011-08-24 |
ATE521384T1 (en) | 2011-09-15 |
JP4824681B2 (en) | 2011-11-30 |
US20070098774A1 (en) | 2007-05-03 |
DK1786504T3 (en) | 2011-10-31 |
CA2576335C (en) | 2012-05-08 |
US20080221524A1 (en) | 2008-09-11 |
AU2012200981A1 (en) | 2012-03-08 |
AU2005278015A1 (en) | 2006-03-02 |
JP2008509723A (en) | 2008-04-03 |
US7479134B2 (en) | 2009-01-20 |
AU2012200981B2 (en) | 2014-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7390318B2 (en) | Needleless microprotrusion elastoplast system | |
EP1086718B1 (en) | Apparatus for the transdermal administration of a substance | |
JP4917540B2 (en) | Method and apparatus for supplying a substance containing a coating | |
JP6334592B2 (en) | Hollow microneedle array and method | |
US8267890B2 (en) | Intradermal delivery device with contoured skin engaging surface geometry | |
EP1581301A2 (en) | Active agent delivery device having composite members | |
KR20150028248A (en) | Protective release sheet for microneedle patch | |
Deulkar et al. | A review on transdermal drug delivery system | |
KR20210125814A (en) | Pump for microneedle | |
WO2019069340A2 (en) | Substance applicator device for application of a product and for control of scratching | |
KR20190127235A (en) | Needle patch having improved delivery of cosmetic solution | |
KR20040039612A (en) | Injector |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ALLERGAN, INC., CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:OLEJNIK, OREST;LYONS, ROBERT T.;GERONDALE, SCOTT J.;REEL/FRAME:015682/0397 Effective date: 20040803 |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |